Pasar al contenido principal

IMPACTO DE LA MATRIZ EXTRACELULAR SOBRE LA BIOLOGIA CELULAR Y LA REPROGRAMACION METABOLICA DE LA FIBROSIS ORGANICA

PID2022-136703OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Enhanced fatty acid oxidation through metformin and baicalin as therapy for COVID-19 and associated inflammatory states in lung and kidney

  • Miguel, Verónica
  • Rey-Serra, Carlos
  • Tituaña, Jessica
  • Sirera, Belén
  • Alcalde-Estévez, Elena
  • Herrero, José Ignacio
  • Ranz, Irene
  • Fernández, Laura
  • Castillo, Carolina
  • Sevilla, Lucía
  • Nagai, James
  • Reimer, Katharina C
  • Jansen, Jitske
  • Kramann, Rafael
  • Costa, Ivan G
  • Castro Morera, Ana
  • Sancho, David
  • Rodríguez González-Moro, José Miguel
  • Lamas Peláez, Santiago
Progressive respiratory failure is the primary cause of death in the coronavirus disease 2019 (COVID-19) pandemic. It is the final outcome of the acute respiratory distress syndrome (ARDS), characterized by an initial exacerbated inflammatory response, metabolic derangement and ultimate tissue scarring. A positive balance of cellular energy may result crucial for the recovery of clinical COVID-19. Hence, we asked if two key pathways involved in cellular energy generation, AMP-activated protein kinase (AMPK)/acetyl-CoA carboxylase (ACC) signaling and fatty acid oxidation (FAO) could be beneficial. We tested the drugs metformin (AMPK activator) and baicalin (CPT1A activator) in different experimental models mimicking COVID-19 associated inflammation in lung and kidney. We also studied two different cohorts of COVID-19 patients that had been previously treated with metformin. These drugs ameliorated lung damage in an ARDS animal model, while activation of AMPK/ACC signaling increased mitochondrial function and decreased TGF-β-induced fibrosis, apoptosis and inflammation markers in lung epithelial cells. Similar results were observed with two indole derivatives, IND6 and IND8 with AMPK activating capacity. Consistently, a reduced time of hospitalization and need of intensive care was observed in COVID-19 patients previously exposed to metformin. Baicalin also mitigated the activation of pro-inflammatory bone marrow-derived macrophages (BMDMs) and reduced kidney fibrosis in two animal models of kidney injury, another key target of COVID-19. In human epithelial lung and kidney cells, both drugs improved mitochondrial function and prevented TGF-β-induced renal epithelial cell dedifferentiation. Our results support that favoring cellular energy production through enhanced FAO may prove useful in the prevention of COVID-19-induced lung and renal damage., This work was supported by grants PID2019-104233RB-I00 and PID2022-136703OB-I00 funded by MCIN /AEI/10.13039/501100011033 / FEDER, Spanish National Research Council CSIC–COV19-096/PIE202020E160, Comunidad de Madrid “NOVELREN” B2017/BMD-3751 and Fundación Renal “Íñigo Alvarez de Toledo”, all from Spain. The CBMSO receives institutional support from Fundación “Ramón Areces”. VM and EA hold a Juan de la Cierva-Formación fellowship from the Spanish Ministry of Science and Innovation (FJC2020-043505-I and FJC2021-046602-I, respectively). VM was supported by a Postdoctoral Long-Term Fellowship from the Federation of European Biochemical Societies (FEBS). CR and BS are recipients of a pre-doctoral fellowship of the FPI Program (BES-2016-076735 and PRE-2020-093831, respectively) from the Spanish Research State Agency
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Multimerization of HIF enhances transcription of target genes containing the hypoxia ancillary sequence

  • Rosell-Garcia, Tamara
  • Rivas-Muñoz, Sergio
  • Kin, Koryu
  • Romero-Albillo, Verónica
  • Alcaraz, Silvia
  • Fernández-Tornero, Carlos
  • Rodríguez-Pascual, Fernando
© 2023 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/)., Transcriptional activity of the hypoxia inducible factor (HIF) relies on the formation of a heterodimer composed of an oxygen-regulated α-subunit and a stably expressed β-subunit. Heterodimeric HIF activates expression by binding to RCGTG motifs within promoters of hypoxia-activated genes. Some hypoxia targets also possess an adjacent HIF ancillary sequence (HAS) reported to increase transcription but whose function remains obscure. Here, we investigate the contribution of the HAS element to the hypoxia response and its mechanism of action, using the HAS-containing prolyl 4-hydroxylase subunit α1 (P4HA1) as a gene model in NIH/3T3 mouse embryonic fibroblasts and HEK293 human embryonic kidney cells. Our HIF overexpression experiments demonstrate that the HAS motif is essential for full induction by hypoxia and that the presence of the tandem HAS/HIF, as opposed to HIF-only sequences, provides HIF proteins with the capacity to form complexes of stoichiometry beyond the classical heterodimer, likely tetramers, to cooperatively potentiate hypoxia-induced transcription. We also provide evidence of the crucial role played by the Fα helix of the PAS-B domain of the HIF1β subunit to support the interaction between heterodimers. Functional analysis showed that human genes containing the HAS/HIF motifs are better responders to hypoxia, and their promoters are enriched for specific transcription factor binding sites. Gene ontology enrichment revealed a predominance of HAS/HIF in genes primarily related to tissue formation and development. Our findings add an extra level of regulation of the hypoxia/HIF signaling through multimerization of HIF proteins on regulatory elements containing the HAS/HIF motifs., This work was supported by a grant from Spanish Ministerio de Ciencia e Innovacion (Proyecto I+D+i “Retos Investigacion” RTI2018- 095631-B-I00 and PID2022-136703OB-I00 to F.R.P.). K.K. was supported by la Caixa postdoctoral junior Leader fellowship (LCF/BQ/PI20/11760009).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Metabolism and bioenergetics in the pathophysiology of organ fibrosis

  • Miguel, Verónica
  • Alcalde-Estévez, Elena
  • Sirera, Belén
  • Rodríguez-Pascual, Fernando
  • Lamas Peláez, Santiago
Fibrosis is the tissue scarring characterized by excess deposition of extracellular matrix (ECM) proteins, mainly collagens. A fibrotic response can take place in any tissue of the body and is the result of an imbalanced reaction to inflammation and wound healing. Metabolism has emerged as a major driver of fibrotic diseases. While glycolytic shifts appear to be a key metabolic switch in activated stromal ECM-producing cells, several other cell types such as immune cells, whose functions are intricately connected to their metabolic characteristics, form a complex network of pro-fibrotic cellular crosstalk. This review purports to clarify shared and particular cellular responses and mechanisms across organs and etiologies. We discuss the impact of the cell-type specific metabolic reprogramming in fibrotic diseases in both experimental and human pathology settings, providing a rationale for new therapeutic interventions based on metabolism-targeted antifibrotic agents., This work was supported by grants from the Spanish Ministry of Science PID2022-136703OB-I00 and PID2019-104233RB-100/AEI/10.13039/501100011033, Comunidad de Madrid Innoren-CM 2022/BMD-7227 and Fundación Renal “Íñigo Álvarez de Toledo”, all from Spain. The CBMSO receives institutional support from Fundación “Ramón Areces”. VM was supported by a FEBS Long-Term Fellowship. VM and EA hold a Juan de la Cierva-Formación fellowship from the Spanish Ministry of Science and Innovation (FJC2020-043505-I and FJC2021-046602-I, respectively). BS is recipient of a pre-doctoral fellowship of the FPI Program (PRE2020-093831) from the Spanish Research State Agency.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

How the Renal Tubule May Adapt to Fuel Shortage

  • Miguel, Verónica
  • Lamas, Santiago
The kidney is an organ that, albeit exhibiting topologic metabolic heterogeneity, derives most of its energy from oxidative metabolism. In particular, in the proximal tubular compartment, constitutive glycolysis is vestigial and the large amount of ATP required to perform its multiple transport functions is obtained through oxidative phosphorylation in the mitochondria using fatty acids as the main source of energy.1 Fatty acid oxidation (FAO) requires the concourse of specialized enzymes for the transport into the mitochondria of long-chain fatty acids (LCFA, more than 13 carbons) that are not freely diffusible. The limiting enzyme in this process is Carnitine palmitoyl transferase type 1 (CPT1), which, by using the carnitine shuttle, facilitates the entry of these molecules into the mitochondrial intermembrane space and ultimately into the mitochondrial matrix. Cpt1a is the predominant isoform in the kidney. The pathophysiologic relevance of FAO reduction in CKD has fostered the study in depth of the role of Cpt1a in kidney human pathology and in experimental models of chronic kidney injury., Verónica Miguel: Ministerio de Ciencia e Innovación, Juan de la Cierva-Formación fellowship (FJC2020-043505-I). Santiago Lamas: Ministerio de Ciencia e Innovación (PID2022-136703OB-I00).